Ekso Bionics Holdings Inc. is evaluating the clinical value of its robotic exoskeleton for spinal cord injury (SCI) patients, reporting the first enrollement in its Walking Improvement for SCI with Exoskeletons (WISE) trial. Thomas Looby, president and CEO, said this is Ekso's first company-sponsored trial.